Scalable Biologics Manufacturing And Antibody Conjugation

The Syracuse Bio Campus in New York presents itself as a U.S.-based partner for mammalian cell production and bioconjugation. Built from a former commercial biopharma manufacturing site, the campus emphasizes experience, regulatory readiness, and flexible support for clients navigating development and outsourcing decisions. Its services span process and facility fit assessments, analytical tech transfer, process development, validation, characterization, PPQ, commercial manufacturing, and CMC support.

View highlights of more than 20 years of biologics manufacturing experience and 62+ regulatory approvals as of January 2026. It also positions the site as a major antibody conjugation center with up to 1,000L bioconjugation capacity, high-potency API containment, and in-house quality support. The site is presented as a capable manufacturing partner for clinical and commercial programs, with end-to-end support from early development through large-scale production.